Learn more about Gastric Electrical Stimulation through:
The aim of this study is to compare the symptoms and healthcare resource utilization costs of patients treated via gastric electrical stimulation (GES) and those treated with traditional pharmacological agents in an outpatient program (MED).
Cutts TF, Luo J, Starkebaum W, et al.
Neurogastroenterology and Motility, 2005
The objective of this study was to investigate the effect of chronic gastric electrical stimulation (GES) on the daily use of prokinetics and antiemetics, hospitalizations, total symptom score (TSS), SF-36 status for health-related quality of life (HQOL), and gastric emptying of a solid meal. The authors evaluated 37 gastroparetic patients preoperatively and 1 year after undergoing GES implant.
Lin Z, McElhinney C, Sarosiek I, et al.
Digestive Diseases and Sciences, 2005
This review of 48 diabetic patients with refractory gastroparesis shows that high-frequency gastric electrical stimulation by a permanently implanted system may significantly improve upper gastrointestinal symptoms, health-related quality of life, nutritional status, and glucose control.
Lin Z, Forster J, Sarosiek I, McCallum RW.
Diabetes Care, 2004
This study investigated the effect of high-frequency/low-energy gastric electrical stimulation for the treatment of gastroparesis. Results included significantly decreased vomiting frequency and gastrointestinal symptoms and improved quality of life.
Abell T, McCallum R, Hocking M, et al.
Gastroenterology,2003
Nutritional depletion, either macronutrient- or micronutrient-related, is common in patients with drug-refractory gastroparesis for which there is often no effective treatment. The authors studied a group of 12 patients who had symptoms of gastroparesis and were a subset of the Gastric ElectroMechanical Stimulation trial of gastric electrical stimulation.
Abell T, Lou J, Tabaa M, et al. J
Parenteral Enteral Nutrition, 2003
In this multicenter study, patients with drug-refractory gastroparesis were reassessed 3, 6, and 12 months after permanent implantation. At 1 year, the average weight gain was 5.5% and 9/14 patients initially receiving enteral or parenteral nutrition were able to discontinue it.
Abell T, VanCutsem E, Abrahamsson H, et al.
Digestion, 2002
Gastroparesis is a chronic gastric motility disorder affecting mostly young and middle-aged women who present with nausea, abdominal pain, early satiety, vomiting, fullness, and bloating. From April 1998 to September 2000, 25 patients underwent gastric pacemaker placement. After placement of the gastric pacemaker, patients rated significantly fewer symptoms and had a modest acceleration of gastric emptying.
Forster J, Sarosiek I, Delcore R, et al.
American Journal of Surgery, 2001
The diagnosis of gastroparesis implies delayed gastric emptying. The diagnostic gold standard is scintigraphy, but techniques and measured endpoints vary widely among institutions. In this study, a simplified scintigraphic measurement of gastric emptying was compared to conventional gastric scintigraphic techniques and normal gastric emptying values defined in healthy subjects.
Tougas G, Eaker E, Abell T, et al.
American Journal of Gastroenterology, 2000
Humanitarian Device: The effectiveness of this device for this use has not been demonstrated.